Skip to content
Fast Company Executive Board

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience.

Profile photo of Sarah Baldry

Sarah Baldry

Chief Marketing Officer, Wysa

Sarah Baldry is Chief Marketing Officer at Wysa, an AI mental health company. She leads global marketing, communications and commercial strategy, helping organisations adopt AI safely, responsibly and at scale. Her work focuses on the practical challenges of introducing transformative technologies into highly regulated environments: trust, governance, behaviour change and the gap between technological capability and real-world implementation. She works closely with healthcare leaders, clinicians, policymakers and enterprise buyers to understand what determines whether innovation succeeds beyond the pilot stage. Sarah writes about AI governance, healthcare transformation and the factors that shape trust in emerging technologies. Her perspective is informed by experience across AI, healthcare, energy and enterprise technology, with a particular interest in how organisations build confidence in new ideas, navigate scrutiny and turn innovation into lasting change. She believes the biggest barriers to innovation are rarely technical. They are trust, incentives, adoption and the ability to turn new capabilities into outcomes that people value.

LOCATION

Boston, MA, USA

SKILLS

Healthcare AI, Responsible AI, Regulated Industries, Workplace Wellbeing, Mental Health

COMPANY

Wysa is the mental health infrastructure layer for AI-driven care. As generative AI becomes easier to embed into health and care environments, the question is no longer whether AI support can be built. It is whether it can be trusted, sustained and safely operated at scale. Wysa provides the clinical safety, behavioural design, escalation logic, care pathway integration and outcomes tracking that make this possible.
This infrastructure enables employers, healthcare, pharma, payers and providers to support people through the emotional and behavioural barriers that determine whether they start, continue and complete the care they need, including adherence to therapy, medication and long-term treatment journeys.
Wysa has supported more than six million people across 95 countries, with over a billion AI conversations to date. Its clinical credibility is reflected in 45+ peer-reviewed publications, FDA Breakthrough Device Designation, and a 93% ORCHA rating with 100% on clinical assurance, the framework used by the NHS to evaluate digital health tools. Wysa is recommended by the NHS and trusted by employers, insurers and healthcare providers worldwide.
Responsible AI sits at the core of how Wysa is built. Safety is treated as infrastructure, not a feature: real-time risk detection, defined escalation pathways, clear boundaries on what AI can and cannot do, and continuous outcomes monitoring, designed in from the ground up.

INDUSTRY

Healthcare & Medical

AREA OF FOCUS

Behaviour Change, AI Governance, Healthcare AI, Digital Health, Mental Health